Shanghai Henlius Biotech Inc.

03/19/2021 | Press release | Distributed by Public on 03/19/2021 05:30

VOLUNTARY ANNOUNCEMENT - APPLICATION FOR CLINICAL TRIAL FOR RECOMBINANT ANTI-VEGF HUMANIZED MONOCLONAL ANTIBODY OPHTHALMIC INJECTION HLX04-O FOR THE TREATMENT OF WET[...]